Trademark: 79343924
Word
AAKINBEV
Status
Registered
Status Code
700
Status Date
Tuesday, February 21, 2023
Serial Number
79343924
Registration Number
6982649
Registration Date
Tuesday, February 21, 2023
Mark Type
4000
Filing Date
Tuesday, May 3, 2022
Published for Opposition
Tuesday, December 6, 2022

Trademark Owner History
Sandoz AG -
Novartis AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all for the foregoing goods being for human use

Trademark Events
Jan 19, 2024
Change Of Owner Received From Ib
Jun 12, 2023
Final Decision Transaction Processed By Ib
May 24, 2023
Final Disposition Notice Sent To Ib
May 24, 2023
Final Disposition Processed
May 21, 2023
Final Disposition Notice Created, To Be Sent To Ib
Feb 21, 2023
Notice Of Registration Confirmation Emailed
Feb 21, 2023
Registered-Principal Register
Dec 13, 2022
Notification Processed By Ib
Dec 6, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 6, 2022
Published For Opposition
Nov 23, 2022
Notification Of Possible Opposition Sent To Ib
Nov 23, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 16, 2022
Notification Of Notice Of Publication E-Mailed
Nov 8, 2022
Refusal Processed By Ib
Nov 1, 2022
Approved For Pub - Principal Register
Oct 31, 2022
Teas/Email Correspondence Entered
Oct 30, 2022
Correspondence Received In Law Office
Oct 30, 2022
Teas Response To Office Action Received
Oct 28, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 28, 2022
Teas Change Of Correspondence Received
Oct 28, 2022
Teas Change Of Domestic Representatives Address
Oct 28, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 28, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 28, 2022
Teas Change Of Owner Address Received
Oct 20, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Oct 20, 2022
Refusal Processed By Mpu
Aug 27, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Aug 26, 2022
Non-Final Action Written
Aug 24, 2022
Assigned To Examiner
Jul 12, 2022
Application Filing Receipt Mailed
Jul 7, 2022
New Application Office Supplied Data Entered
Jul 6, 2022
Limitation From Original Application Entered
Jun 30, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24